Is PML a Tumor Suppressor?
Massimiliano Mazza(University of Milan), Pier Giuseppe Pelicci(Office of Technology Transfer)
Cited by 31
Related Papers
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
|Nature reviews. Cancer|2006|2.2k
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction
|Cell|1992|1.3k
ALK+ lymphoma: clinico-pathological findings and outcome.
|PubMed|1999|569
The Life Span Determinant p66Shc Localizes to Mitochondria Where It Associates with Mitochondrial Heat Shock Protein 70 and Regulates Trans-membrane Potential
|Journal of Biological Chemistry|2004|295